D-cycloserine prevents relational memory deficits and suppression of long-term potentiation induced by scopolamine in the hippocampus by Portero Tresserra, Marta et al.
1  
This is a postprint version of the following article: Portero-Tresserra, M. ; Del Olmo, N. ; Martí-
Nicolovius, M. ; Guillazo-Blanch, G. ; Vale-Martínez, A. (2014) D-cycloserine prevents relational 
memory deficits and suppression of long-term potentiation induced by scopolamine in the 
hippocampus. European Neuropsychopharmacology. Vol. 24, issue 11, p. 1798-1807. ISSN: 0924-
977X  DOI: 10.1016/j.euroneuro.2014.10.002 
 
D-cycloserine prevents relational memory deficits and suppression 
of long-term potentiation induced by scopolamine in the 
hippocampus 
Marta Portero-Tresserra
1
 
Nuria Del Olmo
2
 
Margarita Martí-Nicolovius
1
 
Gemma Guillazo-Blanch
1
 
Anna Vale-Martínez
1
 
Affiliation of all authors: 
 
(1) Departament de Psicobiologia i Metodologia de les Ciències de la Salut, 
Institut de Neurociències, Universitat Autònoma de Barcelona, 
Barcelona, Spain. 
(2) Departamento de Ciencias Farmacéuticas y de la Salud, Facultad de Farmacia, 
Universidad Ceu-San Pablo, Madrid, Spain. 
Running head: Intra-hippocampal DCS reverses SCOP-induced deficits in memory and LTP 
 
Total word/count: 6424 
 
Address for correspondence: 
 
Dr. Anna Vale-Martínez 
 
Departament de Psicobiologia i Metodologia de les Ciències de la Salut, 
Institut de Neurociències, Universitat Autònoma de Barcelona, 
Barcelona (Spain). 
Email: Anna.Vale@uab.cat 
 
Telephone: 34 93 581 3260 / Fax: 34 93 581 2001 
2  
ABSTRACT 
 
Previous research has demonstrated that systemic D-cycloserine (DCS), a partial agonist of the N- 
methyl-D-aspartate receptor (NMDAR), enhances memory processes in different learning paradigms 
and attenuates mnemonic deficits produced by diverse pharmacological manipulations. In the present 
study two experiments were conducted in rats to investigate whether DCS administered in the 
hippocampus may rescue relational memory deficits and improve deficient synaptic plasticity, both 
induced by an intracerebral injection of the muscarinic receptor antagonist scopolamine (SCOP). In 
experiment 1, we assessed whether DCS would prevent SCOP-induced amnesia in an olfactory 
learning paradigm requiring the integrity of the cholinergic system, the social transmission of food 
preference (STFP). The results showed that DCS (10 µg/site) injected into the ventral hippocampus 
(vHPC) before STFP acquisition compensated the 24-h retention deficit elicited by post training intra- 
vHPC SCOP (40µg/site), although it did not affect memory expression in non-SCOP treated rats. In 
experiment 2, we evaluated whether the perfusion of DCS in hippocampal slices may potentiate 
synaptic plasticity in CA1 synapses and thus recover SCOP-induced deficits in long-term potentiation 
(LTP). We found that DCS (50µM and 100µM) was able to rescue SCOP (100µM)-induced LTP 
maintenance impairment, in agreement with the behavioral findings. Additionally, DCS alone (50 µM 
and 100 µM) enhanced field excitatory postsynaptic potentials prior to high frequency stimulation, 
although it did not significantly potentiate LTP. Our results suggest that positive modulation of the 
NMDAR, by activation of the glycine-binding site, may compensate relational memory impairments 
due to hippocampal muscarinic neurotransmission dysfunction possibly through enhancements in LTP 
maintenance. 
 
 
Keywords: acetylcholine; glutamate; NMDA receptors; muscarinic receptors; relational memory; 
synaptic plasticity. 
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1. INTRODUCTION 
 
 
One of the most relevant targets of neuroenhancement strategies is the N-methyl-D-aspartate 
receptor (NMDAR), which is the predominant site for inducing learning-related synaptic plasticity in 
the hippocampus (Lee and Silva, 2009). D-cycloserine (DCS), a partial agonist of the NMDAR that 
binds to the glycine-site and enhances receptor activation in the presence of glutamate (Norberg et al. 
2008), has recently been recognized for its potential in facilitating different cognitive processes. 
Studies in rodents indicate that DCS, administered systemically or intracerebrally, improves numerous 
learning and memory processes in several paradigms (for reviews see Portero-Tresserra et al., 2013b; 
Villarejo-Rodríguez et al., 2010). Furthermore, DCS attenuates mnemonic deficits in aged (Aura and 
Riekkinen, 2000) and stressed rats (Yamamoto et al., 2008), and also in brain damaged rodents 
(Villarejo-Rodríguez et al., 2013; Yaka et al., 2007). Evidence from studies in humans suggests that 
DCS promotes both the consolidation and extinction of conditioned fear (Kalisch et al., 2009) and may 
also enhance declarative learning (Onur et al., 2010). Furthermore, it has also been shown that DCS 
improved cognition in Alzheimer’s disease patients (Tsai et al., 1999). 
Moreover, it has been shown that DCS antagonized memory decreases produced by the 
muscarinic acetylcholine (ACh) receptor antagonist scopolamine (SCOP), which may be considered a 
pharmacological model for cholinergic cognitive impairment (Klinkenberg and Blokland, 2010). Thus, 
the acute systemic pre-learning DCS infusion attenuated SCOP-induced deficits in acquisition of 
spatial tasks (Pitkänen et al., 1995) and brightness discrimination (Andersen et al., 2002). As for 
intracerebral administration, early studies showed that the hippocampus may be a relevant area since 
DCS microinfusions into its dorsal portion ameliorated SCOP-induced spatial working memory 
impairment ( Kishi et al., 1998; Ohno and Watanabe, 1996). Nevertheless, the physiological 
mechanisms by which such effects may occur have been poorly investigated. Several data suggest that 
DCS may improve SCOP-disrupted memory by acting on synaptic plasticity, and particularly long- 
term potentiation (LTP). On the one hand, SCOP administration impaired LTP in the CA1 
hippocampal field (Calabresi et al., 1999; Sánchez et al., 2009) and altered hippocampal glutamate 
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receptor levels (Falsafi et al., 2012). On the other hand, DCS may enhance memory by facilitating 
NMDAR-dependent synaptic potentials and CA1 synaptic plasticity (Rouaud and Billard, 2003; 
Billard and Rouaud, 2007). Accordingly, DCS reinstated LTP in CA1 and improved memory and 
neurological impairments in both brain-damaged (Yaka et al., 2007) and neural cell adhesion 
molecule-deficient mice (Kochlamazashvili et al., 2012). 
In this context, the aim of the present study was to assess whether intra-hippocampal DCS  
may prevent deficits elicited by muscarinic blockade, both at a behavioral and physiological level. 
Thus, in the first experiment, we sought to confirm whether an acute DCS pre-learning treatment, as 
has been reported with intra-prelimbic cortex (PLC) administration (Portero-Treserra et al., 2013b), 
reverses SCOP-induced deficits in social transmission of food preference (STFP), which is a paradigm 
of social learning involving an ethologically meaningful test of olfactory memory that is considered a 
relational memory test with no explicit spatial components (Eichenbaum, 2000). STFP requires the 
integrity of the cholinergic system (Vale-Martinez et al., 2002) specifically in the ventral hippocampus 
(vHPC) (Carballo-Marquez et al., 2007), where a substantial increase in ACh release has been 
demonstrated after learning (Gold et al., 2011). The relevance of the vHPC has also been demonstrated 
in studies showing enhanced c-fos activity (Ross and Eichenbaum, 2006) and CREB phosphorylation 
(Countryman et al., 2005) in STFP learning. In the second experiment, we explored whether DCS may 
rescue putative deficits induced by SCOP in the induction/maintenance of LTP. To that end, 
electrophysiological recordings in CA1 synapses were carried out under the influence of DCS and 
SCOP perfusions (alone and in combination) in hippocampal slices both before and after a high 
frequency stimulation (HFS) protocol. 
 
 
2. EXPERIMENTAL PROCEDURES 
Experiment 1 
Subjects 
 
Fifty male Wistar rats, obtained from our laboratory breeding stock (Prolabor, Charles River 
Laboratories, Arbresle, France), with a mean age of 94.53 days (SD=6.231) and a mean weight of 
402.795 g (SD=33.86) at the beginning of the experiment, were used as observer subjects. An 
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additional set of 36 male Wistar rats (mean age=57.25 d, SD=4.89; mean weight 225.17 g, SD=47.55) 
served as demonstrator subjects. Juvenile demonstrator rats were used in order to avoid fighting and 
favor social interaction (Vale-Martinez et al., 2002). Procedures for housing, food restriction and 
habituation are explained in detail elsewhere (Portero-Tresserra et al., 2013a). All procedures were 
carried out in compliance with the European Community Council Directive for care and use of 
laboratory animals (86/609/ECC) and with the Generalitat de Catalunya authorization (DOGC 2450 
7/8/1997, DARP protocol number 5959). 
Surgery 
 
Observer rats were anesthetized with isoflurane and underwent stereotaxic implantation of 
bilateral chronic guide cannulae in the vHPC: AP, -5.0mm; ML, ±5.0 mm; and DV, -6.8 mm (Paxinos 
and Watson, 1997), following procedures explained in detail elsewhere (Carballo-Marquez et al., 
2009). After surgery, rats were returned to their home cages for 10 days (four for recovery, four for 
food restriction and two for rehabituation to ground food) before behavioral training. 
Microinfusion procedure 
 
The rats received 10µg/hemisphere of DCS (Sigma-Aldrich, Madrid, Spain) or phosphate- 
buffered saline (PBS; 0.1M, pH 7.4) infusions 20 min before STFP acquisition and 40µg/hemisphere 
SCOP (Scopolamine Hydrobromide USP, Sigma–Aldrich, Madrid, Spain) or PBS immediately after 
the social learning session. The solutions were infused bilaterally in a volume of 0.5 µl / hemisphere 
for 2 min (plus 1 min to allow for diffusion) following procedures described previously (Portero- 
Tresserra, et al., 2013a). The dose of DCS selected has been established previously to facilitate 
olfactory learning tasks when injected into the PLC or the basolateral amygdala (Portero-Tresserra et 
al., 2013a,b; Villarejo-Rodríguez et al., 2010), and other learning tasks, such as extinction of fear 
conditioning and appetitive learning, when injected into the basolateral amygdala or the infralimbic 
cortex (Peters & de Vries 2013; Walker et al. 2002). The SCOP dose was chosen on the basis of a pilot 
study showing that intra vHPC injections of 40µg of SCOP disrupted STFP memory consolidation 
without inducing motor alterations (unpublished data). 
Behavioral procedure 
 
Habituation to food jars 
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The apparatus for STFP habituation, acquisition and testing is described in more detail in 
Portero-Tresserra et al. (2013b). After seven days of food restriction and prior to surgery, observers 
and demonstrators were habituated for three days to powdered chow (Scientific Animal Food and 
Engineering, Augy, France). A similar procedure was repeated 7 d after surgery for the observers (two 
45-min rehabituation sessions). Subsequently, animals were again food-restricted for two days before 
the training–testing sessions began. 
STFP acquisition and test 
 
The STFP training followed procedures explained elsewhere (Portero-Tresserra et al., 2013a). 
 
Essentially, the task began when a demonstrator was allowed to eat food flavored with 2.2% cocoa 
(Oxfam Fairtrade, Gent, Belgium) or 1% cinnamon (Carmencita, Alicante, Spain) for 30 min. 
Immediately after, observers and demonstrators interacted for 30 min. All observers were tested 24 h 
after acquisition (45-min test) on the basis of previous studies showing amnesic effects after such a 
time period in SCOP-treated rats (Carballo-Marquez et al., 2009). A preference score (percentage of 
trained food) was calculated as follows: 100 x (weight of trained food eaten/weight of all food eaten). 
The number of times each observer sniffed the muzzle, body or anogenital region of the demonstrator, 
fighting and grooming (social interaction), and the number of forepaws (jar climbs during STFP test) 
were recorded (JVC, Everio Model GZ-X900). To rule out olfactory alterations due to the DCS and 
SCOP infusions, an additional olfactory perception test (described in Portero-Tresserra et al., 2013a) 
was conducted. 
Histology 
 
Perfusions and brains’ post fixation were performed as explained elsewhere (Carballo- 
Marquez et al., 2009). Coronal 40-µm sections were cut on a cryostat (Shandom Cryotome FSE, 
Thermo Electron Corporation, Massachusetts, USA), mounted and processed for acetylcholinesterase 
histochemistry and examined essentially as described previously (Portero-Tresserra et al., 2013a). 
Data analysis 
 
The main analysis of the variable percentage of trained food was performed by means of 
ANOVA (PASW v20) with the group factor as the independent variable (VEH, DCS, SCOP and 
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DCS+SCOP). Specific between-group comparisons were performed and the Bonferroni correction was 
used. In addition, a one-sample t test against a constant (50) was used for each group to determine 
whether the percentage of trained food eaten was different from the chance level (50%). 
To evaluate whether all the animals had similar opportunities of learning (similar social 
interaction levels), we carried out an ANOVA considering group as the independent variable, and the 
dependent variables were sniffs of demonstrator’s muzzle, body and anogenital region, fighting and 
grooming. Pearson correlation tests were used in order to examine the relationship between such 
variables and the percentage of trained food selected. Additional ANOVAs were also used to analyze 
total food eaten and jar climbs, which evaluated motivation to eat and explore, respectively. Mixed 
analyses of variance were carried out to analyze neophobia, with regular food (mean g of food eaten 
during the last rehabituation session prior to training) and new food (mean g of total food eaten, 
trained + untrained, during the test) as dependent variables. 
Regarding the olfactory test, an ANOVA was applied considering group (VEH, DCS, SCOP 
and DCS+SCOP) as the independent variable, and latency in finding the buried cookie as the 
dependent variable. 
 
 
Experiment 2 
Subjects 
Electrophysiological assays were carried out in 10-week old male Wistar rats (Prolabor, 
Charles River Laboratories, Arbresle, France) in accordance with the European Communities Council 
Directive (86/609/EEC) for the care and use of laboratory animals. 
Electrophysiological recordings in hippocampal slices 
 
Procedures of the electrophysiological experiments are precisely described in Miguéns et al. 
(2011). Drugs (DCS and SCOP) were prepared as stock solutions in PBS, stored frozen in the dark, 
and diluted to final concentration immediately before use. After obtaining stable synaptic responses 
for at least 20 min (baseline period), the different pharmacological treatments (DCS 50µM, DCS 
100µM, SCOP 100µ, DCS 50µM + SCOP 100µM and DCS 100µM + SCOP 100µM) were perfused 
for 40 min. After 20 min of drug perfusion, Schaffer collateral fibers were tetanized with three 100-Hz 
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pulses of 100 µs duration every 20 s (HFS) to induce saturated-LTP. Following LTP induction, 
recording was carried out for 60 min, 20 min with drug and 40 min with KRB solution alone. 
Data analysis 
Data are expressed as the mean±SEM. The mean values of the initial slope of the fEPSP 
correspond to the averages of 1min intervals. In all experiments potentiation was assessed by 
analyzing the mean slope of the fEPSP measured at different time points after HFS application. A 
value of p<0.05 was considered statistically significant. 
To evaluate whether the administration of the different drugs produced changes in the basal 
synaptic transmission, one-way ANOVAs (PASW v20) were performed in order to compare the mean 
of the fEPSP slope for 20 min before HFS of each experimental group (DCS 50µM, DCS 100µM, 
SCOP 100 µM, DCS 50µM + SCOP 100µM and DCS 100µM + SCOP 100µM) against the mean of 
the fEPSP slope during the 20-min baseline of the VEH group. To evaluate the effects of the drugs on 
LTP, a mixed ANOVA was carried out, in which the between-subject factor was group (VEH, DCS 
50µM, DCS 100µM, SCOP100µM, DCS 50µM + SCOP 100µM and DCS 100µM + SCOP 100µM) 
and the within-subject factor was time (the last 10 minutes of the recording). Finally, the percentage of 
potentiation in the final recording (percentage of potentiation during the last 10 min of recording in 
relation to 10 min of the basal line prior to HFS) was considered as the dependent variable and the 
group factor as the independent variable (which included 6 categories). Contrast analyses were 
performed by means of Fisher’s LSD. Differences were considered significant when p<0.05. 
 
 
3. RESULTS 
Experiment 1 
Histology 
 
For the final sample we only considered rats with their cannula tips bilaterally located in the 
vHPC within the area delimited by CA3 and CA1, and the cannulae were located from -4.52 to -5.20 
mm posterior to bregma (Figure 1). Eight rats were excluded from behavioral data analyses since their 
cannulae were incorrectly implanted (n=5) or due to technical problems during the infusion (n=3). 
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Thus, the final sample was made up of 42 subjects distributed into the following groups: VEH (n=10), 
DCS (n=10), SCOP (n=12) and DCS+SCOP (n=10). 
Behavioral testing 
 
As depicted in Figure 2, statistically significant between-group differences in the percentage 
of trained food eaten were found [F[3,41]=8.858, P=0.0001]. Contrast analyses showed statistically 
significant differences between SCOP and the remaining groups: VEH (P=0.006), DCS (P=0.002) and 
DCS+SCOP (P<0.0001). SCOP rats apparently exhibited no preference for the trained food since it 
was not significantly different from chance level (t[11]=-1.675, P=0.122) whereas the other groups 
performed significantly above chance level (t[9]’s > 3.41 and P’s < 0.01). The analysis of the social 
interaction measures showed no statistically significant group effects in any of the variables (muzzle: 
F[3,41]=1.880, P=0.149; body: F[3,41]=1.522, P=0.224; anogenital: F[3,41]=0.785, P=0.510; fighting: 
F[3,41]=0.724, P=0.544 and grooming F[3,41]=0.169, P=0.917). Nor were there any statistically 
 
significant correlations between such variables and the percentage of trained food. 
 
No statistically significant between-group differences were observed in exploration of both 
food jars (jar climbs) (F[3,41]=0.472, P=0.706) and in the total amount of food consumed during the test 
session (F[3,41]=0.257, P=0.856). In the analysis of possible neophobic effects, mixed ANOVA showed 
a significant effect of food (F[1,38]=4.611, P=0.038) but no significant effects of group (F[3,38]=1.081, 
P=0.369) or group x food interaction (F[3,38]=1.614, P=0.202). 
The performance in this task did not seem to be related to changes in olfactory sensitivity as 
no statistically significant between-group differences were observed when the latency to find a buried 
sweet-smelling cookie was analyzed 24h after injections (F[3,41]= 0.139, P = 0.936). 
 
Experiment 2 
 
After a 20-min basal period and stable fEPSP responses, the different drugs [DCS 50µM 
(n=5), DCS 100µM (n=4), SCOP 100µM (n=8), DCS 50µM+SCOP 100µM (n=5), DCS 
100µM+SCOP 100µM (n=4)] were added into the KRB in the corresponding groups. The application 
of DCS to hippocampal slices induced a slight potentiation of basal synaptic transmission in all the 
groups (see Figures 3 and 4). The ANOVA comparing the fEPSP responses 20 min after drug 
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perfusion (time before HFS) versus the 20-min of baseline period of the VEH group showed 
statistically significant differences in the following groups: DCS 50µM (F[1,11]=8.862, P=0.014), DCS 
100µM (F[1,10]=13.824, P=0.005), DCS 50µM+SCOP 100µM (F[1,13]=6.514, P=0.025) and DCS 
100µM+SCOP 100µM (F[1,12]=5.258, P=0.043), but not in the SCOP 100µM group (F[1,14]=0.467, 
P=0.506) (Figure5A). 
After HFS and following 20 min of drug perfusion, the effects of the drugs on LTP were 
analyzed (Figures 3 and 4). The ANOVA of the last 10 minutes of recording showed that the group 
(F[5,31]=3.919, P=0.007) and time (F[9,279]=6.434, P<0.0001) factors were statistically significant, but 
not the interaction group x time [F[45,279]=1.104, P=0.311]. Specifically, the group differences were 
found between the SCOP 100µM group and the remaining groups: VEH (P=0.024), DCS 50µM 
(P<0.0001), DCS 100µM (P=0.003), DCS 50µM+SCOP 100µM (P=0.05) and DCS 100µM+SCOP 
100µM (P=0.033) (Figures 3 and 4). Hence, the administration of DCS offset the deficit on the LTP 
maintenance induced by SCOP. Additionally, the analysis of the potentiation percentage in the final 
recording indicated statistically significant between-group differences [F[5,31]=2.866, P=0.0306]. The 
differences were appreciated between the SCOP 100µM group vs. VEH (P=0.019), DCS 
50µM+SCOP 100µM (P=0.05), DCS 100µM+SCOP 100µM (P=0.05), DCS 50µM (P=0.002) and 
DCS 100µM (P=0.023) (Figure 5B). 
 
 
4. DISCUSSION 
 
The present study provides behavioral and electrophysiological evidence that the potentiation 
of glutamatergic activity in the hippocampus, with microinfusion of the partial NMDAR agonist DCS, 
rescues relational memory deficits and in-vitro LTP maintenance impairment, both induced by the 
administration of the muscarinic antagonist SCOP. In the experiment 1, vHPC administration of DCS 
prior to social interaction prevented the SCOP-induced amnesia in the 24-h memory test, as the trained 
food preference of the DCS+SCOP group was significantly higher than the chance level and that of the 
SCOP group, but not thanVEH and DCS groups. These results cannot be attributed to alterations in 
olfactory perception, social investigation, neophobic responses or motor activity. The counteraction of 
SCOP-induced deficits is consistent with early reports suggesting that the hippocampus may be a 
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critical region for the action of DCS in the reversion of SCOP-induced impairments in spatial working 
memory (Kishi et al., 1998; Ohno and Watanabe, 1996). Previous research also showed that the 
systemic pre-learning injection of DCS attenuated SCOP-induced deficits both in spatial (Pitkänen et 
al., 1995) and non-spatial paradigms (Andersen et al., 2002). Therefore, the present results provide 
more evidence as to a potential pervasive role of DCS in the reversion of memory deficits induced by 
different causes, such as cholinergic or glutamatergic dysfunction (Kawabe et al., 1998), aging (Aura 
and Riekkinen, 2000), stress (Yamamoto et al., 2008), traumatic brain injury and hippocampal, medial 
septal or thalamic lesions (Villarejo-Rodríguez et al., 2013; Yaka et al., 2007). Data from experiment 2 
showed that the two doses of DCS enhanced the potentiation percentage in SCOP-treated slices at the 
end of registering, which would suggest that the cellular mechanism underlying the reversion of 
SCOP-induced amnesia in STFP may involve long-term synaptic plasticity. Our results show that both 
basal and post HFS synaptic transmission under 50 or 100 µM of DCS reached a ceiling effect in 
control slices. Moreover, it could be considered that 100 µM of DCS in SCOP-treated slices also came 
to a ceiling because HFS produced an identical potentiation in all the experimental situations due to 
the saturated-LTP induced. Nevertheless, the maintenance of the potentiation is the really interesting 
effect of DCS in the reversion of the non-lasting LTP under SCOP treatment. The present 
physiological data agree with studies showing that DCS can reverse deficits in hippocampal LTP 
induced by head injury (Yaka et al., 2007), NCAM-deficiency (Kochlamazashvili et al., 2012), or 
aging (Billard and Rouaud, 2007). It has been shown that DCS not only facilitated NMDAR activation 
and synaptic plasticity in young rats, but was significantly more potent in aged animals, thus reversing 
the age-related deficit of NMDAR-mediated LTP and long-term depression (LTD) (Billard and 
Rouaud, 2007). 
As to the behavioral effects of DCS in non-SCOP treated rats, the present study showed that 
DCS did not improve STFP memory, which is consistent with data from previous experiments 
showing that DCS in the PLC ameliorated SCOP-induced deficits in the STFP task, but did not 
enhance memory when injected in control rats (Portero-Tresserra et al., 2013a). Such findings would 
suggest, as discussed previously (Portero-Tresserra et al., 2013a), that DCS may enhance implicit or 
procedural tasks, but that its facilitative influence on relational paradigms seems to be more restricted. 
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Another factor that may be considered to explain the effects of DCS in control subjects is the targeted 
cognitive process, since some studies showed a beneficial effect of DCS specifically in the extinction 
of fear conditioning (Ren et al., 2013). In contrast, in the present experiment DCS administration 
probably affected the original learning/early consolidation as the drug was injected prior to STFP 
training. Regarding the physiological effects of DCS, data from experiment 2 showed that DCS in non 
SCOP-treated slices did not enhance hippocampal LTP. This contrasts with an earlier study showing 
that DCS facilitated synaptic plasticity of glutamatergic transmission in the CA1 field, lowering the 
threshold to induce a lasting potentiation (Rouaud and Billard, 2003). Methodological factors may 
explain divergence in findings since the Rouaud and Billard (2003) study used a protocol inducing a 
shorter potentiation. The present data also indicated that the administration of DCS in CA1, before 
HFS, increased the magnitude of the fEPSP recorded both in slices treated and untreated with SCOP. 
Thus, all the DCS groups showed an increased percentage in the fEPSP slope from the 20-min 
baseline to the initial 20-min drug presence condition (7.78%, 11.85%, 6.38% and 7.78%). These 
findings may be interpreted as an enhancement in synaptic transmission (although it did not 
significantly endure after HFS), which would agree with the Rouaud and Billard (2003) work 
indicating that DCS facilitated NMDAR-mediated fEPSPs in the CA1 region of rat hippocampal 
slices. Such results found in the CA1 hippocampal region also confirm an early report demonstrating 
that DCS increased in vivo the excitability of dentate granule cells (Pitkänen et al., 1994). 
Nevertheless, the fact that DCS enhanced NMDAR-dependent synaptic potentials but not LTP or 
behavioral memory in non-SCOP groups was not wholly unexpected as earlier studies indicated that 
DCS had a more robust effect in animals showing a certain cognitive deficit (Aura and Riekkinen, 
2000; Billard and Rouaud, 2007). 
The present results also confirm that the infusion of SCOP (40µg/hemisphere) in the vHPC 
immediately after the STFP acquisition produced a striking deficit in the 24h-memory test, detected by 
the poor performance of the SCOP group, which did not differ from the chance level and was 
significantly worse than that of the VEH group. Such data corroborate the contribution of muscarinic 
receptors in the consolidation of this social form of relational memory as STFP impairments had also 
been observed when a lower dose of SCOP (20µg) was administered in the vHPC or the PLC 
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(Carballo-Marquez et al., 2009; Portero-Tresserra et al., 2013a). Interestingly, muscarinic receptors 
appear to contribute to the recognition of socially relevant odors but not neutral odors, since systemic 
administration of SCOP significantly disrupted urine estrous odor but no mint odor habituation 
(Miranda et al. 2009). The importance for STFP acquisition of the cholinergic transmission has also 
been demonstrated in a microdialysis study showing a significant increase (200%) of ACh release in 
the vHPC after exposure to a rat that had eaten the novel food, which was not found in the PLC (Gold 
et al., 2011). Such effects are consistent with the involvement of the cholinergic system in regulating 
the salience of odors during active sensing of the olfactory environment (Rothermel et al., 2014), 
which agrees with the proposed role of ACh in attentional mechanisms. The current 
electrophysiological data also demonstrated that the SCOP (100 µM) perfusion in hippocampal slices 
significantly suppressed the LTP maintenance in CA1 synapses, as indicated by the lower percentage 
of potentiation in the last 10 min of recording by the SCOP group vs. the remaining groups, thus 
confirming previous findings (Sánchez et al., 2009). Moreover, detrimental effects of SCOP on LTP 
have also been found in CA1 synapses in vivo (Ovsepian et al., 2004) and in corticostriatal synapses 
(Calabresi et al., 1999). In agreement with the above, it has been reported that muscarinic receptor 
activation facilitates the induction of LTP in rat hippocampal slices (Buchanan et al., 2010), which 
would corroborate that such receptors are a crucial event in this form of synaptic plasticity. 
Taken together, the results from both experiments point to an interactive relationship between 
glutamatergic and cholinergic transmission in memory modulation, previously suggested by 
behavioral pharmacological studies (Ohno and Watanabe, 1996). For instance, concomitant 
administration of sub-threshold doses of SCOP and NMDA antagonists induced amnesia in inhibitory 
avoidance and spatial learning (Khakpai et al., 2012) and sub-effective doses of NMDA and 
physostigmine exerted memory-enhancing properties (Jafari-Sabet, 2006). There is also evidence at 
the cellular level indicating the interaction between cholinergic and glutamatergic systems in 
mediating memory processes on the grounds of their involvement in synaptic plasticity. Markram and 
Segal (1990) demonstrated that the administration of ACh increases the probability of generating 
hippocampal NMDA-dependent LTP. Furthermore, the activation of muscarinic receptors can also 
lead to LTD of NMDAR-mediated synaptic transmission (Jo et al., 2010). In this sense, it has been 
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shown that M1 muscarinic receptors induce the opening of NMDA receptors through the inhibition of 
SK channels (Buchanan et al., 2010). Moreover, cooperation between cholinergic and glutamatergic 
receptors would seem to be essential to induce BDNF-dependent long-lasting memory storage 
(Navakkode and Korte, 2012). Additionally, other mechanisms by which SCOP may disrupt LTP have 
been suggested, such as down-regulation of protein kinase C and nitric oxide (Saraf et al., 2010), 
which are required for LTP induction and maintenance (Knafo et al., 2012). Therefore, it is widely 
known that muscarinic ACh receptors and NMDAR are important for learning and memory, although 
the specific manner in which they interact is less understood (Doguc et al., 2012). Indeed, few studies 
had assessed the brain regions where such an interaction may take place (Khakpai et al., 2012) or the 
function of intracerebral DCS as a preventive treatment for mnemonic deficits produced by 
cholinergic deficiency (Portero-Tresserra et al., 2013a), which enhances the significance of the current 
research. 
In summary, in the present study we found a correspondence between behavioral and cellular 
findings. In both experiments, the administration of DCS was able to rescue SCOP-induced 
impairments since the DCS+SCOP groups showed comparable results in STFP memory and 
electrophysiological recording. Consequently, DCS effects on STFP memory may be interpreted in 
terms of enhancing hippocampal LTP, which may be considered as a crucial element in memory or 
other forms of experience-dependent plasticity. Although there is no general consensus regarding LTP 
as a model for the synaptic changes that contribute to the neural circuit modifications underlying all 
types of experience-dependent plasticity, accumulating evidence would suggest that this mechanism 
has important functional roles in many brain areas and in different circumstances (Malenka, 2003). 
Our results, therefore, provide functional evidence that DCS may be helpful in reducing memory 
impairments associated with cholinergic depletion, probably by enhancing LTP. Hence, our findings 
support the use of NMDA-glycine site agonists, such as DCS, as potential treatments for the 
alleviation of memory alteration occurring in neurodegenerative or neurological diseases. 
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FIGURE LEGENDS 
 
 
FIGURE 1. Histology. (A) Photomicrograph (10x) of acetylcholinesterase staining at the vHPC 
area (AP, 5.20 mm posterior to Bregma) showing the cannulae tracks and the microinjector tips 
of a representative subject. (B) Micro-injector tip placements throughout the rostral-caudal 
extent vHPC for each group: VEH (open circles), DCS (filled circles), SCOP (open triangles), 
and DCS+SCOP (filled triangles). [CA2: field CA2 of hippocampus, CA3: field CA3 of 
hippocampus, DG: dentate gyrus] 
 
 
FIGURE 2. Effects of D-cycloserine on STFP. Percentage of the trained food selected, 
expressed as the mean percentage (±SEM) of the total amount of food consumed in the STFP 
24h-test (** P<0.01, *** P<0.001). 
 
 
FIGURE 3. Effects of D-cycloserine on LTP. The symbols represent the fEPSP slope values 
from CA1 hippocampal slices in the VEH (open circles), DCS 50µM (filled circles) and DCS 
100µM (filled triangles) groups. The upper traces are the averages of the fEPSPs recorded 
during the basal period (a, thin trace), following high frequency stimulation (HFS, indicated by 
arrows) (b, thick trace) and final record (c, dash trace). Calibration: 1 mV, 2 ms. 
 
 
FIGURE 4. Effects of D-cycloserine and scopolamine on LTP. The symbols represent the 
fEPSP slope values from CA1 hippocampal slices in the DCS 100µM + SCOP100µM (filled 
triangles), DCS 50µM + SCOP100µM (filled circles), SCOP 100µM (grey circle) and VEH 
(open circles) groups. The upper traces are the averages of the fEPSPs recorded during the basal 
period (a, thin trace), after HFS (b, thick trace) and final record (c, dash trace). Calibration: 1 
mV, 2 ms. 
 
 
FIGURE 5. Effects of D-cycloserine before and after high-frequency stimulation. (A) Mean 
fEPSP slope during the 20-min basal period for VEH group and the 20-min drug perfusion prior 
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HFS for the remaining groups (* P<0.05 and ** P<0.01). (B) Mean fEPSP slope (% Control) 
during the last 10 min of recording in control medium (* P<0.05 and ** P<0.01). 
